Women with uterine fibroids equal to or larger than 16 weeks in size can be safely and effectively managed with abdominal myomectomy.
Women with uterine fibroids equal to or larger than 16 weeks in size can be safely and effectively managed with abdominal myomectomy.
Researchers evaluated 91 myomectomies performed for large fibroids during a 5-year period. They found mean operating time to be 236 minutes and mean estimated blood loss to be 794 mL. Seven women required homologous transfusion, one suffered a bowel injury, one experienced a bladder injury, one developed a wound infection, and one required surgery for an incarcerated small bowel. None of the women had a uterine sarcoma or adenocarcinoma, and none required conversion to hysterectomy.
Limitations of the research include lack of a control group, inclusion of only procedures performed by a single surgeon, and lack of confirmation of uterine size with ultrasound volume calculations. But the outcomes seem to compare favorably with those reported in studies of hysterectomies performed for uteri of similar size.
Multicomponent intervention boosts quality of life in overactive bladder patients
March 15th 2024A recent study reveals the efficacy of a cognitive behavior therapy program, showcasing significant improvements in health-related quality of life among women grappling with moderate to severe overactive bladder.
Read More
Optimizing pain management post urogynecologic surgery with restrictive opioid protocol
March 14th 2024A recent study suggests that restrictive opioid prescribing protocols post-urogynecologic surgery are as effective as standard protocols, emphasizing the importance of multimodal analgesia and outpatient follow-up for patient satisfaction.
Read More
Study finds no increased stress urinary incontinence recurrence risk from childbirth
March 11th 2024A recent meta-analysis challenged common clinical assumptions, finding no increased risk of stress urinary incontinence recurrence or need for reoperation after subsequent pregnancy and childbirth following a midurethral sling procedure.
Read More
Cefepime–Taniborbactam outperforms meropenem in treating complicated UTI
February 15th 2024A recent study demonstrated the superior efficacy of cefepime–taniborbactam over meropenem for managing complicated urinary tract infections, suggesting a promising treatment option amid rising antibiotic resistance challenges.
Read More